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Abstract
Introduction Fecal incontinence is a debilitating condition
with considerable impact on quality of life. The artificial
bowel sphincter may be used as a treatment option in severe
cases in which no less invasive form of therapy is
sufficient.
Results Risk of infection and mechanical failure is of
particular concern in this artificial device.
Conclusion We report a rare late complication: balloon
dilation due to hypertonic fillings.
Keywords Artificial bowel sphincter.Complications
Fecal incontinence is a socially disabling condition for
which several surgical treatments are available [1]. The
artificial bowel sphincter (ABS; Acticon, American Medical
Systems, Minnetonka, MN) (Fig. 1) is a well-publicized
treatment option for severe intractable fecal incontinence
which offers the patient a chance for continence restoration
and improved quality of life [2–5]. We report an unusual late
complication of this procedure.
As the implantation procedure has been described
extensively elsewhere, we will only briefly summarize the
technique [3]. The ABS system consists of three parts: cuff,
pump, and pressure-regulating balloon. The cuff is placed
around the anal canal by blunt dissection using two lateral
incisions. The pump is implanted in the labia majora or
scrotum. The pressure-regulating balloon is placed through
a transverse, suprapubic incision to accommodate insertion.
The rectus abdominis muscles are retracted to expose the
space of Retzius where the balloon is implanted.
The pressure-regulating balloon controls the amount of
pressure exerted on the anal canal by the occlusive cuff. It is
made of silicone elastomer and is provided in three pressure
ranges(81–90cmH2O; 91–100 cm H2O; 101–110 cm H2O).
In this case a 91–100 cm H2O balloon had been implanted.
The Acticon neosphincter is filled with contrast solutions
or normal saline. The solution must be sterile and isotonic
to minimize the transfer of fluid across the silicone
membrane, which is semipermeable. Contrast media diluted
with sterile water are used as a filling solution to improve
imaging of the device. The presence of particles in the
filling solution can affect the operation of the pump.
A now 30-year-old male received an ABS to control
continence in 2001 after a severe pelvic trauma with a
rupture of the sphincter complex in 1999. This patient was
evaluated for an unknown progressive swelling in his
abdomen as well as urinary and defecation difficulties at
the emergency department at Medisch Spectrum Twente in
June 2009. The swelling was noticed several months earlier
but discarded by the patient as related to his trauma surgery
or starting adipositas.
Physical examination showed no abnormal findings
other than a palpable swelling in the lower abdomen of
approximately 15 cm. Abdominal ultrasound showed a
cystic lesion in the lower abdomen with debris of an
unknown origin. A computed tomography (CT) scan
(Fig. 2) revealed a large cystic swelling in the lower pelvic
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DOI 10.1007/s00384-011-1159-yarea with an open connection to the tubing of the ABS
system. The CT scan also showed a stretched rectus
abdominis muscle overlying the reservoir indicating a
normal position of the balloon. The process was therefore
attributed to an abnormal swelling of the pressure-
regulating balloon. Based on the CT scan, a volume of
approximately 1,400 cc was measured as opposed to a
normal volume of 43 cc.
Patient underwent surgery to remove the balloon by
median laparotomy (Figs. 3 and 4). The balloon was
explanted and the remaining system was closed and left in
situ with the aim to replace the balloon in a second stage.
Thereafter, a double-barreled colostomy was performed.
Clear fluid from the balloon was collected for analysis. The
patient recovered without signs of infection and was
eligible for implantation of a new pressure-regulating
balloon. During this second procedure at Maastricht
University Medical Centre, fluid was recovered from the
remaining system and preserved for analysis. As this fluid
was dark and cloudy and therefore suspected to be
contaminated the cuff and tubing were explanted as well
and replaced with a new ABS. The contrast solution
(Omnipaque 240 mgI/ml, Nycomed with sterile water)
used to fill the new balloon was also preserved and sent for
analysis. The patient recovered without any problems and
the ABS was activated at the outpatient clinic 1 month later.
Analysis of the fluid retrieved from the dilated balloon
showed an osmolality of 297 milliosmoles per kilogram
(mOsm/kg) and a density of 1.00 g per milliliter (g/ml).
Fluid retrieved from the remaining system showed an
osmolality of 306 mOsm/kg and a density of 0.99 g/ml.
Fig. 2 CT scan revealed a large cystic swelling in the lower pelvic
area
Fig. 3 Balloon removal by median laparotomy
Fig. 4 Balloon removal by median laparotomy
Fig. 1 The artificial bowel sphincter
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about 275–299 mOsm/kg. Normal human blood density is
approximately 1.06 g/ml. The test results from the collected
fluid are isotonic. The contrast solution however showed an
osmolality of 337 mOsm/kg and a density of 1.15 g/ml.
This is a hypertonic fluid despite being the exact solution as
recommended by the manufacturer.
The osmotic pressure gradient across the semipermeable
balloon is opposed by the tension of the balloon creating an
equilibrium. We speculate that the fluid inside the balloon
had reached equilibrium with the surrounding tissues before
explantation. This was confirmed by analysis of the
osmolality. An explanation for the late stage increase in
size of the balloon may be balloon fatigue and stretching of
the pores (the pressure is inversely proportional to the
radius of the balloon) allowing for a larger inflow of
particles including proteins establishing equilibrium rela-
tively quickly and with a much larger total volume. This
was confirmed after analysis of ion and protein content
which was similar to plasma values according to blood tests
prior to surgery with the exception of total amount of
protein. This was still lower than the plasma value and
probably a result of particle size.
No other insights have been provided by the manufacturer
American Medical Systems after consultation with their
engineers.
Since the introduction of the neosphincter, the use of
ABS has been limited because of a high complication rate.
Common problems with the system are mechanical failure,
perineal erosion, and infection of which the latter occurs
most frequent. A systematic review by Mundy et al.
concludes the ABS to be of uncertain benefit and to
possibly be harmful for patients. Infection was reported in
12 out of 14 studies included averaging 22.5% and erosion
in 17.4%. Surgical revision was reported in 13 out of 14
studies included averaging 42.6%. Carmona et al. also
found a high rate of morbidity (100%, 1 infection, 5
erosions and 19 further surgeries in 17 patients) but
conclude that in patients without complications, the
ABS produces considerable results. A case series
published by Melenhorst et al. showed 7 (21.2%)
infections and 26 further surgeries in 33 patients.
Stringent patient selection as well as patient information
is strongly recommended [6, 7].
Prior to this report, no mechanical failure on the basis of
hypertonic balloon contrast fluids has been reported.
Surgeons implanting the ABS as a neosphincter need to
be aware of the possibility of balloon dilation due to
hypertonic fillings next to other complications arising with
its use.
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